NCT01455194 - Effect of High Dose Ciclesonide on Asthma Control | Biotech Hunter

Enrollment

520

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Bronchial Asthma

Interventions

DRUG

Ciclesonide

During the treatment period subjects will inhale two puffs of either 40, 80 or 160 μg ciclesonide in the morning and the evening (corresponding to a total daily dose of 160, 320 or 640 μg)

Trial Locations (30)

Unknown

Buenos Aires

Capital Federal, Buenos Aires

Rosario

Rosario-Santa Fe

Salta

San Miguel de Tucumán

Florianópolis

Goiânia

Porto Alegre

Rio de Janiero

Santo André

São Paulo

Sorocaba

Berlin

Bonn

Landsberg

Rudersdorf

Schwetzingen

Beersheba

Haifa

Jerusalem

Kfar Saba

Petah Tikva

Rehovot

Tel Aviv

Barnaul

Moscow

Novosibirsk

Saint Petersburg

Tomsk